BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Founded

2006

Raised

$37.9M

Follow us

Also headquartered in Cambridge

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

13 Feb 2012

$25,500,000

Venture capital (Series D)

29 Jun 2010

$12,400,000

Venture capital (Series C)